Shuttle Pharmaceuticals Holdings (SHPH) Total Non-Current Liabilities (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $8.4 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 338.44% year-over-year to $8.4 million; the TTM figure through Mar 2026 stood at $8.4 million (up 338.44% YoY), while the FY2025 annual figure was $8.1 million, up 646.73% from the prior year.
• Total Non-Current Liabilities was $8.4 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $8.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $8.4 million in Q1 2026 to a low of $945765.0 in Q2 2023.
• Historically, Total Non-Current Liabilities has averaged $2.7 million across 4 years, with a median of $1.9 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities decreased 26.58% in 2024, then jumped 646.73% in 2025.
• A 4-year view of Total Non-Current Liabilities shows it stood at $1.5 million in 2023, then fell by 26.58% to $1.1 million in 2024, then surged by 646.73% to $8.1 million in 2025, then gained by 3.91% to $8.4 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $8.4 million (Q1 2026), $8.1 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.